Several overseas research institutes have conducted “replication studies” using N-NOSE, the world’s first biological screening technology, focusing on the reproducibility of our method. The research confirmed that the technology is reproducible as a method of identifying cancer with great accuracy, and results have been published in academic journals.
HIROTSU BIO SCIENCE Corporation is proud to announce the opening of a store on Tmall Global, the largest cross-border EC platform in China opera . . .2023.08.22
Hirotsu Bio Science Inc. (Headquarters: Chiyoda-ku, Tokyo, Representative Director: Takaaki Hirotsu) has signed a memorandum of understanding wi . . .2023.06.13
On Thursday, March 16, "DAVOS 2023 DEBRIEFING" was held by the Consulate of Switzerland in Osaka.Our CMO/CGO, Shunsuke Mizushima, was invited as . . .2023.03.20